Ignite Creation Date:
2024-05-06 @ 2:23 AM
Last Modification Date:
2024-10-26 @ 11:18 AM
Study NCT ID:
NCT02037165
Status:
COMPLETED
Last Update Posted:
2019-07-05
First Post:
2014-01-14
Brief Title:
Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak PtP N2P2-component Amplitude of Laser Somatosensory Radiant-heat Evoked Potentials LEP in UVBUltraviolet-Irradiated Skin in Healthy Male Volunteers
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
Effectiveness of Two Different Doses of BI 1026706 on the Overall Peak-to-Peak PtP N2P2-component Amplitude of Laser Somatosensory Radiant-heat Evoked Potentials LEP in UVB Ultraviolet-Irradiated Skin in Healthy Male Volunteers a Single-blinded Randomised Placebo-controlled Single-dose Five-way Crossover Study
Status:
COMPLETED
Status Verified Date:
2019-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
To investigate the influence of different doses of BI 1026706 on the primary endpoint PtP-amplitude LEP in UV skin compared to placebo
The comparison of both doses of BI 1026706 to celecoxib in the UVB treatment
Comparison of both doses of BI 1026706 to placebo and pregabalin in the capsaicin treatment
Exploration of the pharmacokinetics of BI 1026706
Exploration of safety and tolerability of BI 1026706
The comparison of both doses of BI 1026706 to celecoxib in the UVB treatment
Comparison of both doses of BI 1026706 to placebo and pregabalin in the capsaicin treatment
Exploration of the pharmacokinetics of BI 1026706
Exploration of safety and tolerability of BI 1026706
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2012-005691-33 | EUDRACT_NUMBER | EudraCT | None |